Evommune, Inc. (EVMN)
6.82
+0.51
(+8.08%)
USD |
NYSE |
Oct 29, 16:00
6.70
-0.12
(-1.76%)
After-Hours: 20:00
Evommune Price : 6.82 for Oct. 29, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 28, 2026 | 5.50 | 7.21 | 5.22 | 6.31 | 6.522M |
| Oct 27, 2026 | 5.13 | 5.26 | 4.96 | 5.16 | 1.302M |
| Oct 26, 2026 | 5.10 | 5.31 | 5.02 | 5.13 | 322218.0 |
| Oct 23, 2026 | 5.18 | 5.18 | 4.94 | 5.10 | 280829.0 |
| Oct 22, 2026 | 5.13 | 5.365 | 5.095 | 5.21 | 255757.0 |
| Oct 21, 2026 | 5.41 | 5.521 | 5.125 | 5.17 | 383385.0 |
| Oct 20, 2026 | 5.33 | 5.70 | 5.33 | 5.38 | 382463.0 |
| Oct 19, 2026 | 5.30 | 5.43 | 5.125 | 5.27 | 422784.0 |
| Oct 16, 2026 | 5.97 | 6.00 | 5.09 | 5.17 | 986709.0 |
| Oct 15, 2026 | 5.90 | 6.00 | 5.81 | 5.93 | 579086.0 |
| Oct 14, 2026 | 5.79 | 5.96 | 5.64 | 5.77 | 574844.0 |
| Oct 13, 2026 | 6.05 | 6.05 | 5.85 | 5.88 | 805295.0 |
| Oct 12, 2026 | 6.09 | 6.22 | 6.04 | 6.05 | 384152.0 |
| Oct 09, 2026 | 6.40 | 6.44 | 6.175 | 6.25 | 557955.0 |
| Oct 08, 2026 | 6.18 | 6.44 | 6.02 | 6.41 | 691980.0 |
| Oct 07, 2026 | 6.51 | 6.525 | 6.15 | 6.22 | 2.112M |
| Oct 06, 2026 | 6.67 | 6.67 | 6.08 | 6.61 | 1.007M |
| Oct 05, 2026 | 6.86 | 7.216 | 6.52 | 6.65 | 1.365M |
| Oct 02, 2026 | 7.25 | 7.28 | 6.74 | 6.92 | 1.745M |
| Oct 01, 2026 | 8.25 | 8.30 | 6.99 | 7.21 | 1.525M |
| Sep 30, 2026 | 8.40 | 8.525 | 8.11 | 8.26 | 724199.0 |
| Sep 29, 2026 | 8.36 | 8.65 | 8.11 | 8.35 | 807597.0 |
| Sep 28, 2026 | 8.40 | 8.435 | 8.12 | 8.39 | 660788.0 |
| Sep 25, 2026 | 8.78 | 8.78 | 8.33 | 8.49 | 542051.0 |
| Sep 24, 2026 | 8.73 | 8.90 | 8.25 | 8.80 | 992271.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 60.48 |
| Oncolytics Biotech, Inc. | 0.4273 |
| Sangamo Therapeutics, Inc. | 0.118 |
| Sarepta Therapeutics, Inc. | 19.22 |
| Anixa Biosciences, Inc. | 3.32 |
Price Related Metrics
| PS Ratio | 22.65 |
| PEG Ratio | -0.1185 |
| Price to Book Value | 0.8914 |
| Earnings Yield | -41.48% |
| Market Cap | 247.44M |
| PEGY Ratio | -0.1185 |